United States - English - NLM (National Library of Medicine)

mission pharmacal company - acetohydroxamic acid (unii: 4rz82l2gy5) (acetohydroxamic acid - unii:4rz82l2gy5) - acetohydroxamic acid 250 mg - acetohydroxamic acid is indicated as adjunctive therapy in patients with chronic urea-splitting urinary infection. aha is intended to decrease urinary ammonia and alkalinity, but it should not be used in lieu of curative surgical treatment (for patients with stones) or antimicrobial treatment. long-term treatment with aha may be warranted to maintain urease inhibition as long as urea-splitting infection is present. experience with aha does not go beyond 7 years. a patient package insert should be distributed to each patient who receives aha. acetohydroxamic acid should not be used in: a. patients whose physical state and disease are amenable to definitive surgery and appropriate antimicrobial agents b. patients whose urine is infected by non-urease producing organisms c. patients whose urinary infections can be controlled by culture-specific oral antimicrobial agents d. patients whose renal function is poor (i.e., serum creatinine more than 2.5 mg/dl and/or creatinine clearance less than 20 ml/min) e. female patients who do not evidence a satisfactory method of contraception f. patients who are pregnant acetohydroxamic acid may cause fetal harm when administered to a pregnant woman. aha was teratogenic (retarded and/or clubbed rear leg at 750 mg/kg and above and exencephaly and encephalocele at 1,500 mg/kg) when given intraperitoneally to rats. aha is contraindicated in women who are or may become pregnant. if this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be informed of the potential hazard to the fetus. children with chronic, recalcitrant, urea-splitting urinary infection may benefit from treatment with aha. however, detailed studies involving dosage and dose intervals in children have not been established. children have tolerated a dose of 10 mg/kg/day, taken in two or three divided doses, satisfactorily for periods up to one year. close monitoring of such patients is mandatory.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - acetohydroxamic acid - oral capsule - 250mg

Ireland - English - HPRA (Health Products Regulatory Authority)

thornton & ross limited - ferrous fumarate; folic acid - capsule, hard - 305 mg/0.35 milligram(s) - iron in combination with folic acid; ferrous fumarate

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - ferrous fumarate; folic acid - capsule, hard - 305 mg/0.35 milligram(s) - iron in combination with folic acid; ferrous fumarate

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

imported (spain) - acetohydroxamic acid - oral capsule - 250mg

Malta - English - Medicines Authority

laboratoire innotech international 22 avenue aristide briand, arcueil 94110, france - film-coated tablet - ferrous gluconate 60 mg folic acid 0.40 mg - antianemic preparations

Canada - English - Health Canada

duchesnay inc - beta-carotene; vitamin e (dl-alpha tocopheryl acetate); ascorbic acid (ascorbic acid); vitamin b1 (thiamine mononitrate); vitamin b2 (riboflavin); nicotinamide; vitamin b6 (pyridoxine hydrochloride); d-pantothenic acid (calcium d-pantothenate); magnesium (magnesium oxide); iodine (potassium iodide); iron (ferrous fumarate); copper (cupric oxide); zinc (zinc oxide); folic acid; vitamin b12 (cyanocobalamin); vitamin d3 (cholecalciferol); calcium (calcium carbonate) - tablet - 1.6mg; 13.8mg; 120mg; 3mg; 3.4mg; 20mg; 10mg; 5mg; 50mg; 0.15mg; 35mg; 2mg; 15mg; 1.1mg; 12mcg; 250unit; 300mg - beta-carotene 1.6mg; vitamin e (dl-alpha tocopheryl acetate) 13.8mg; ascorbic acid (ascorbic acid) 120mg; vitamin b1 (thiamine mononitrate) 3mg; vitamin b2 (riboflavin) 3.4mg; nicotinamide 20mg; vitamin b6 (pyridoxine hydrochloride) 10mg; d-pantothenic acid (calcium d-pantothenate) 5mg; magnesium (magnesium oxide) 50mg; iodine (potassium iodide) 0.15mg; iron (ferrous fumarate) 35mg; copper (cupric oxide) 2mg; zinc (zinc oxide) 15mg; folic acid 1.1mg; vitamin b12 (cyanocobalamin) 12mcg; vitamin d3 (cholecalciferol) 250unit; calcium (calcium carbonate) 300mg - vitamins & minerals

Canada - English - Health Canada

duchesnay inc - folic acid; vitamin e (dl-alpha tocopheryl acetate); ascorbic acid (ascorbic acid); vitamin b1 (thiamine mononitrate); vitamin b2 (riboflavin); nicotinamide; vitamin b6 (pyridoxine hydrochloride); d-pantothenic acid (calcium d-pantothenate); magnesium (magnesium oxide); iodine (potassium iodide); iron (ferrous fumarate); copper (cupric oxide); zinc (zinc oxide); vitamin b12 (cyanocobalamin); vitamin d3 (cholecalciferol); calcium (calcium carbonate); beta-carotene - tablet - 5mg; 13.8mg; 120mg; 3mg; 3.4mg; 20mg; 10mg; 5mg; 50mg; 0.15mg; 35mg; 2mg; 15mg; 12mcg; 250unit; 300mg; 1.6mg - folic acid 5mg; vitamin e (dl-alpha tocopheryl acetate) 13.8mg; ascorbic acid (ascorbic acid) 120mg; vitamin b1 (thiamine mononitrate) 3mg; vitamin b2 (riboflavin) 3.4mg; nicotinamide 20mg; vitamin b6 (pyridoxine hydrochloride) 10mg; d-pantothenic acid (calcium d-pantothenate) 5mg; magnesium (magnesium oxide) 50mg; iodine (potassium iodide) 0.15mg; iron (ferrous fumarate) 35mg; copper (cupric oxide) 2mg; zinc (zinc oxide) 15mg; vitamin b12 (cyanocobalamin) 12mcg; vitamin d3 (cholecalciferol) 250unit; calcium (calcium carbonate) 300mg; beta-carotene 1.6mg - vitamins & minerals